Pediatric Oncology

Choose NeoGenomics for Your Pediatric Oncology Testing

NeoGenomics Laboratories is fully focused on propelling cancer diagnostics and research forward. NeoGenomics is CAP-accredited, CLIA-certified laboratory providing the full spectrum of cancer reference services: consultation, flow cytometry, IHC, cytogenetics, FISH, and molecular analysis. With 15 years' experience serving pathologists and oncologists in all types of cancer, NeoGenomics is renewing its focus on pediatric cancer to provide the best of these tools to this community.

Pediatric oncology needs the best diagnostic and research partners available.  With broad expertise and a comprehensive in-house test menu spanning multiple methodologies, we are uniquely positioned to support the diagnosis and care of pediatric cancer patients. 

Here are some of the reasons clients choose NeoGenomics:

  • Comprehensive and complete menu with more than 630 total tests including 160+ molecular tests run in-house
  • Liquid biopsies target ctDNA/RNA in easily-collected peripheral blood samples for solid tumors and hematologic diseases
  • COG Certification in cytogenetics with testing performed in our Fort Myers, Florida facility
  • Rapidly-evolving test menu means we are highly responsive to guideline changes and new therapy options
  • Tech-only programs for pathologists are available in  flow cytometry, FISH, and IHC
  • Pharma Services supporting research and trials in academia and industry are known for flexibility and rapid response 

Selected Testing Indications

  • AML FISH Panel
  • BCR-ABL1 p210/p190 or p230 PCR
  • MDS FISH Panel
  • MPN FISH Panel
  • NeoLAB™ Liquid Biopsies
  • NeoTYPE™ Cancer Profiles
  • NHL FISH Panel
  • Universal Fusion/Expression Profile (1385 Genes)

Highlighted Assays

  • Acute lymphoblastic leukemia (ALL)
  • Acute myeloid leukemia (AML)
  • Chronic myeloid leukemia (CML)
  • Hodgkin lymphoma Juvenile myelomonocytic leukemia (JMML)

Selected Testing Indications

  • Acute lymphoblastic leukemia (ALL)
  • Acute myeloid leukemia (AML)
  • Juvenile myelomonocytic leukemia (JMML)
  • Myelodysplastic syndrome (MDS)
  • Solid tumors positive in NeoTYPE™ Solid Tumor Profile

Highlighted Assays

  • AML Profile
  • MDS/CMML Profile
  • Myeloid Disorders Profile
  • FLT3 Mutation Analysis
  • Inv(16), CBFB-MYH1  Translocation
  • NPM1 Mutation Analysis
  • RUNX1-RUNX1T1 (AML1-ETO) Translocation, t(8;21)
  • Solid Tumor Monitor

Selected Testing Indications

  • Acute myeloid leukemia (AML)
  • Brain tumors
  • Juvenile myelomonocytic leukemia (JMML)
  • Liposarcoma
  • Melanoma
  • Myeloproliferative neoplasm (MPN)
  • Myelodysplastic syndrome (MDS)
  • Other solid tumors

Highlighted Assays

  • NeoTYPE AML Prognostic Profile
  • NeoTYPE Brain Profile
  • NeoTYPE JMML Profile
  • NeoTYPE Liposarcoma Fusion Profile
  • NeoTYPE MDS/CMML Profile
  • NeoTYPE Melanoma Profile
  • NeoTYPE MPN Profile
  • NeoTYPE Precision Solid Tumor Profile
  • NeoTYPE Soft Tissue Profile

Selected Testing Indications

  • Acute lymphoblastic leukemia (ALL)
  • Acute myeloid leukemia (AML)
  • Chronic myeloid leukemia (CML)
  • Juvenile myelomonocytic leukemia (JMML)
  • Myelodysplastic syndrome (MDS)
  • Myeloproliferative neoplasm (MPN)
  • Non-Hodgkin lymphoma (NHL)
  • T-cell lymphoma

Highlighted Assay

The Children’s Oncology Group (COG) has approved NeoGenomics to analyze cytogenetics cases in our Fort Myers, Florida location. We are currently accepting blood and bone marrow specimens for oncology chromosome analysis for patients enrolled in research studies with COG, and we are working toward additional approvals.

Selected Testing Indications

  • Glioblastoma
  • Gliomas

Highlighted Assays

  • ATRX Mutation Analysis
  • BRAF Rearrangement FISH
  • EGFR Amplification FISH
  • EGFRvIII Analysis
  • IDH1/2 Mutation Analysis
  • MGMT Promoter Methylation Analysis
  • MYCN (n-MYC) Amplification FISH
  • NeoTYPE™ Brain Tumor Profile
  • PDGFRA Amplification FISH

Selected Testing Indications

  • Ewing’s Sarcoma
  • Osteosarcoma
  • Pediatric Sarcoma
  • Rhabdomyosarcoma

Highlighted Assays

  • DDIT3 (CHOP) FISH
  • EWSR1 FISH
  • MDM2 FISH
  • NeoTYPE® Liposarcoma Fusion Profile
  • NGS Comprehensive Sarcoma Fusion Profile
  • NGS Ewing Sarcoma Fusion Profile
  • NGS Non-Ewing Sarcoma Fusion Profile
  • NGS Pediatric Sarcoma Fusion Profile
  • NGS Rhabdomyosarcoma Fusion Profile
  • SS18 (SYT) FISH

Highlighted Assays

  • BRAF Mutation Analysis
  • BRAF Rearrangement FISH
  • NeoSITE® Melanoma FISH Panel
  • NeoTYPE® Melanoma Profile
  • PD-L1, 22C3 FDA IHC
  • PD-L1 28-8 FDA IHC
  • TERT Promoter Mutation Analysis

Selected Testing Indications

  • Adrenocortical carcinoma (ACT)
  • Aplastic anemia
  • Brain tumors
  • Diamond-Blackfan anemia
  • Fanconi anemia
  • Leukemia
  • Retinoblastoma
  • Sarcoma
  • Severe congenital neutropenia (SCN)

Highlighted Assays

  • Inherited Bone Marrow Failure Panel
  • Hereditary Cancer Susceptibility for Pediatrics